Frontiers in Aging Neuroscience

Papers
(The TQCC of Frontiers in Aging Neuroscience is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease209
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases192
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature133
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia128
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study125
Cellular Senescence in Brain Aging120
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia119
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis104
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects101
The Impact of Disease Comorbidities in Alzheimer's Disease98
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia93
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases84
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab80
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease80
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–201979
Astrocyte Senescence and Alzheimer’s Disease: A Review79
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases77
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey75
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease74
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?73
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease71
Astroglia and Tau: New Perspectives69
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype69
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease66
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases60
The Role of Resting-State Network Functional Connectivity in Cognitive Aging60
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease60
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain59
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management58
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort57
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review57
Alzheimer’s Disease: An Update and Insights Into Pathophysiology57
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases56
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease54
Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo54
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress53
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough51
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease51
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke51
Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration49
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?49
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies48
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review48
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury48
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy47
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease47
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis47
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the 46
Stem Cells of the Aging Brain45
Identifying Early Mild Cognitive Impairment by Multi-Modality MRI-Based Deep Learning44
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study44
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease43
Role of the Extracellular Matrix in Alzheimer’s Disease43
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction43
Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia42
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine42
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease42
Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson’s Disease42
Clinical and Genetic Aspects of CADASIL41
Hearing Loss and Cognition: What We Know and Where We Need to Go41
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications41
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin41
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study40
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target40
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)40
Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study40
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration40
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease39
Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology39
Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease39
ADVIAN: Alzheimer's Disease VGG-Inspired Attention Network Based on Convolutional Block Attention Module and Multiple Way Data Augmentation38
Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech38
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration38
Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype37
The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment37
Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity36
Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis36
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease36
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research36
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action36
Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies35
Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging35
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease35
The Mitochondrial Unfolded Protein Response: A Hinge Between Healthy and Pathological Aging35
Feature Selection and Combination of Information in the Functional Brain Connectome for Discrimination of Mild Cognitive Impairment and Analyses of Altered Brain Patterns35
The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease35
Neuregulins in Neurodegenerative Diseases35
Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants35
Secreted Chaperones in Neurodegeneration35
Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice35
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration35
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?34
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention34
Predicting Alzheimer’s Disease Conversion From Mild Cognitive Impairment Using an Extreme Learning Machine-Based Grading Method With Multimodal Data34
Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease34
Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain34
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease34
Dl-3-n-Butylphthalide Promotes Remyelination and Suppresses Inflammation by Regulating AMPK/SIRT1 and STAT3/NF-κB Signaling in Chronic Cerebral Hypoperfusion33
Glymphatic Dysfunction in Patients With Ischemic Stroke33
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis33
Age-Related Changes in Pain Perception Are Associated With Altered Functional Connectivity During Resting State33
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago33
Local Brain-Age: A U-Net Model32
Characterization of EEG Data Revealing Relationships With Cognitive and Motor Symptoms in Parkinson's Disease: A Systematic Review32
Brain Ischemia as a Prelude to Alzheimer's Disease32
Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?32
COVID-19-Related Intracerebral Hemorrhage32
Graph Theory Analysis Reveals Resting-State Compensatory Mechanisms in Healthy Aging and Prodromal Alzheimer’s Disease32
Effectiveness of an Innovative Cognitive Treatment and Telerehabilitation on Subjects With Mild Cognitive Impairment: A Multicenter, Randomized, Active-Controlled Study32
Effectiveness and Safety of Acupuncture for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis32
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown32
Mitochondrial Behavior in Axon Degeneration and Regeneration32
Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study32
Acoustic and Language Based Deep Learning Approaches for Alzheimer's Dementia Detection From Spontaneous Speech32
Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease32
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease32
Resilience and Psychobiological Response to Stress in Older People: The Mediating Role of Coping Strategies31
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders31
Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model31
Progress of RAGE Molecular Imaging in Alzheimer’s Disease31
Neurogranin: A Potential Biomarker of Neurological and Mental Diseases31
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines31
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes31
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States30
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum30
Identification of Circular RNA hsa_Circ_0003391 in Peripheral Blood Is Potentially Associated With Alzheimer's Disease30
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease30
Propionate and Alzheimer’s Disease30
Role of mTOR-Regulated Autophagy in Synaptic Plasticity Related Proteins Downregulation and the Reference Memory Deficits Induced by Anesthesia/Surgery in Aged Mice30
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases29
Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ42 Burden at the Early Stage of Alzheimer’s Disease in APP/PS1 Transgenic Mice29
Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease29
The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders29
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy29
Microstructural Alterations in Hippocampal Subfields Mediate Age-Related Memory Decline in Humans29
Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease29
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H28
Functional MRI-Specific Alterations in Executive Control Network in Mild Cognitive Impairment: An ALE Meta-Analysis28
Dual-Task Exercise to Improve Cognition and Functional Capacity of Healthy Older Adults28
Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy28
Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders28
Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke28
Functional MRI-Specific Alterations in Salience Network in Mild Cognitive Impairment: An ALE Meta-Analysis28
Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases28
Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer’s Disease27
Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy27
Mitochondrial Homeostasis and Signaling in Parkinson’s Disease27
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation27
The Future of GDNF in Parkinson's Disease27
Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease27
Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism27
Intracranial Atherosclerotic Plaque Characteristics and Burden Associated With Recurrent Acute Stroke: A 3D Quantitative Vessel Wall MRI Study27
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease27
Factors Associated With the Dilation of Perivascular Space in Healthy Elderly Subjects27
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy27
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease27
Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer’s Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance27
Prevalence and Associated Risk Factors of Cognitive Frailty: A Systematic Review and Meta-Analysis27
“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease27
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease26
Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke26
Axonal Degeneration in AD: The Contribution of Aβ and Tau26
Autonomic Nervous System and Cognitive Impairment in Older Patients: Evidence From Long-Term Heart Rate Variability in Real-Life Setting26
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis26
The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer’s Disease26
Electrophile Signaling and Emerging Immuno- and Neuro-modulatory Electrophilic Pharmaceuticals26
Alzheimer’s Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural26
Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke26
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis26
The Emerging Role of Neuropeptides in Parkinson’s Disease26
Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson’s Disease: A Prospective Pilot Study26
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction26
Transcranial Electric Current Stimulation During Associative Memory Encoding: Comparing tACS and tDCS Effects in Healthy Aging26
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology25
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid25
Age-Related Alterations in DTI Metrics in the Human Brain—Consequences for Age Correction25
The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis25
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors25
Regular Tai Chi Practice Is Associated With Improved Memory as Well as Structural and Functional Alterations of the Hippocampus in the Elderly25
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform25
Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification25
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease25
Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson’s Disease25
A Large-Scale Open Motion Dataset (KFall) and Benchmark Algorithms for Detecting Pre-impact Fall of the Elderly Using Wearable Inertial Sensors25
Vascular Dementia and Underlying Sex Differences24
Hypoxia-Inducible Factor 1α and 2α Have Beneficial Effects in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Aged Rats24
Structural and Functional Hippocampal Changes in Subjective Cognitive Decline From the Community24
Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together24
Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients24
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models24
Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease24
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota24
The Human Body as a Super Network: Digital Methods to Analyze the Propagation of Aging24
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study24
Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage24
Electroacupuncture Ameliorates Cognitive Impairment by Inhibiting the JNK Signaling Pathway in a Mouse Model of Alzheimer’s Disease24
Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease24
Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity24
The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation23
Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans23
Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function23
The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis23
Acupuncture for the Treatment of Alzheimer's Disease: An Overview of Systematic Reviews23
The Influence of Demographics and Vascular Risk Factors on Glymphatic Function Measured by Diffusion Along Perivascular Space23
Altered Brain Function in Cerebral Small Vessel Disease Patients With Gait Disorders: A Resting-State Functional MRI Study23
A New Rat Model of Chronic Cerebral Hypoperfusion Resulting in Early-Stage Vascular Cognitive Impairment23
Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node23
Transneuronal Degeneration in the Brain During Glaucoma23
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints23
Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype23
LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke23
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival 22
Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets22
Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease22
Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach22
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)22
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases22
Age-Related Decreases in Interhemispheric Resting-State Functional Connectivity and Their Relationship With Executive Function22
Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer’s Disease Patient Astrocytes Impair Neuroglial and Vascular Components22
Impaired Topographical Organization of Functional Brain Networks in Parkinson’s Disease Patients With Freezing of Gait22
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway22
A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks22
Convergent Functional Changes of Default Mode Network in Mild Cognitive Impairment Using Activation Likelihood Estimation22
Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease22
Acupuncture-Related Therapies for Parkinson's Disease: A Meta-Analysis and Qualitative Review21
Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers21
Contributions of Hippocampal Volume to Cognition in Healthy Older Adults21
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease21
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue21
Metabolomic and Lipidomic Profiling of Preoperative CSF in Elderly Hip Fracture Patients With Postoperative Delirium21
Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging21
Longitudinal Characterization and Biomarkers of Age and Sex Differences in the Decline of Spatial Memory21
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities21
AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review21
Gray Matter Deterioration Pattern During Alzheimer's Disease Progression: A Regions-of-Interest Based Surface Morphometry Study21
Stress Granules and Neurodegenerative Disorders: A Scoping Review21
Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation21
Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age21
Altered Cholesterol Homeostasis in Huntington’s Disease21
Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis21
The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease21
Inflammation, Cognition, and White Matter in Older Adults: An Examination by Race21
Functional Disorganization of Small-World Brain Networks in Patients With Ischemic Leukoaraiosis21
Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE421
The Roles of Optogenetics and Technology in Neurobiology: A Review21
Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis21
Revealing a Novel Landscape of the Association Between Blood Lipid Levels and Alzheimer's Disease: A Meta-Analysis of a Case-Control Study21
Language Impairment in Alzheimer’s Disease—Robust and Explainable Evidence for AD-Related Deterioration of Spontaneous Speech Through Multilingual Machine Learning21
Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis21
Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice21
0.065701961517334